ADORA2A and Huntington disease: This finding is consistent with observations in R6/2 mice, where 5hmC levels were reduced at specific CpG sites within exon m2 of ADORA2A. This leads to speculation that changes in DNA methylation states may serve as potential biomarkers for the diagnosis of HD (Villar-Menéndez et al., 2013).